An Overlook of Cagrilintinide and Semaglutide as it Progresses Through Phase 3 Trials US$ 20.45 Min. order: 1 piece ★★★★★ 4.5 (217 reviews) Sold : Login>>
Novo Nordisk announces positive results for CagriSema in type 2 diabetes US$ 25.93 Min. order: 1 piece ★★★★★ 4.7 (86 reviews) Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 25.11 Min. order: 1 piece ★★★★★ 4.3 (104 reviews) Sold : Login>>
Targeting the incretin system in obesity and type 2 diabetes mellitus US$ 27.92 Min. order: 1 piece ★★★★★ 4.9 (200 reviews) Sold : Login>>